QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 3m-visa-medtronic-and-more-on-cnbcs-final-trades

Joshua Brown of Ritholtz Wealth Management named 3M Co. as his final trade on CNBC's Halftime Report, while other experts s...

 medtronic-recalls-some-video-laryngoscopes-due-to-increased-risk-for-battery-overheat-explosion

Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions.

 fda-says-abbott-diabetes-care-inc-issues-recall-for-certain-freestyle-libre-3-sensors-due-to-risk-for-inaccurate-high-glucose-readings-medtronic-removes-some-mcgrath-mac-video-laryngoscopes-updates-use-instructions-for-others-due-to-increased-risk-for-battery-overheat--explosion

- Reuters

 pacemate-acquires-medtronics-paceart-optima-system-no-financial-terms-disclosed

PaceMate®, a pioneer in cardiac data management and remote monitoring, announced today the acquisition of the Paceart Optima™ s...

 truist-securities-maintains-hold-on-medtronic-raises-price-target-to-90

Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and raises the price target from $85 t...

 barclays-maintains-overweight-on-medtronic-raises-price-target-to-105

Barclays analyst Matt Miksic maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $104 to $105.

 medtronic-receives-fda-approval-for-expanded-mri-labeling-on-percept-pc-percept-rc-and-activa-pc-rc-sc-devices

- Reuters 

 oppenheimer-maintains-perform-on-medtronic-raises-price-target-to-94

Oppenheimer analyst Steven Lichtman maintains Medtronic (NYSE:MDT) with a Perform and raises the price target from $92 to $94.

 piper-sandler-maintains-neutral-on-medtronic-raises-price-target-to-90

Piper Sandler analyst Matt O'Brien maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $85 to...

 rbc-capital-reiterates-sector-perform-on-medtronic-maintains-92-price-target

RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $92 price target.

 wells-fargo-maintains-overweight-on-medtronic-raises-price-target-to-106

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $105 t...

 baird-maintains-neutral-on-medtronic-raises-price-target-to-90

Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $82 to $90.

 stifel-maintains-hold-on-medtronic-raises-price-target-to-87

Stifel analyst Rick Wise maintains Medtronic (NYSE:MDT) with a Hold and raises the price target from $85 to $87.

 wall-street-eases-bonds-rise-us-dollar-falls-to-8-month-low-whats-driving-markets-tuesday

It’s a relatively uneventful session on Wall Street, but with a slightly worsening risk sentiment as all U.S. equity indices tr...

 needham-reiterates-hold-on-medtronic

Needham analyst Mike Matson reiterates Medtronic (NYSE:MDT) with a Hold.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION